why choose us

300×250 Ad Slot

Research Article: Characteristics of Real-World Patients with High-Risk BRAFVE/K-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program

Date Published: 2023-11-11

Introduction:
The incidence of melanoma has increased worldwide in the last decades, although a recent study in the US showed that it appears to have stabilized in recent years. – In Italy, cutaneous melanoma is the second most frequent cancer diagnosis in men under years of age, and the annual average incidence of new skin melanoma diagnoses is . per , for men and . per , for women.

Read more

300×250 Ad Slot